Aclaris Therapeutics, Inc. — Director's Dealing 2016

Sep 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aclaris Therapeutics, Inc. (ACRS)
CIK: 0001557746
Period of Report: 2016-09-15

Reporting Person: Walker Neal (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-15	Common Stock	J	81686	$0.00	Acquired	867193	Direct
2016-09-15	Common Stock	J	4790	$0.00	Acquired	871983	Direct

Footnotes

F1: Liquidating distribution from NeXeption, LLC, of which the reporting person is a non-managing member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement.

F2: Pro rata distribution from NST, LLC, of which the reporting person is a non-managing member, in accordance with NST, LLC's Limited Liability Company Operating Agreement.